Dr. Feld graduated from medical school at the University of Toronto in 1997 and then completed residency programs in Internal Medicine and Gastroenterology. Following his clinical training, Dr. Feld focused on developing skills in clinical and laboratory research in liver disease, with a particular interest in viral hepatitis. He completed a clinical research fellowship in hepatology and then spent 4 years doing clinical and laboratory research in the Liver Diseases Branch of the National Institutes of Health. He received a Masters of Public Health with a focus on Infectious Diseases as a Sommer Scholar from Johns Hopkins University and has worked extensively abroad, maintaining a strong interest in International Health. Currently, Dr. Feld is clinician-scientist based at the Toronto General Hospital, Toronto Centre for Liver Disease and the McLaughlin-Rotman Centre for Global Health.

Dr. Brianna Norton is an assistant professor of medicine in the Divisions of General Internal Medicine and Infectious Diseases at Montefiore Medical Center/Albert Einstein College of Medicine. Her clinical work includes the treatment of HIV, Hepatitis C and opioid dependence in the primary care setting. She conducts research to improve linkage to HCV care and treatment for people who inject drugs. She is also the medical director of the NY Harm Reduction Educators, a syringe exchange program in East Harlem and the South Bronx.

Dr. Marina Klein is Professor of Medicine, McGill University, Montreal, Canada in the Division of Infectious Diseases/Chronic Viral Illnesses where she is research director. Her clinical interests focus on treatment of patients with HIV and chronic viral hepatitis. She is a prominent researcher in clinical and epidemiologic aspects of HIV and Hepatitis C co-infection and leads a Canadian Institutes of Health Research (CIHR) funded prospective cohort study of over 1700 HIV-HCV co-infected patients to study the interaction of these chronic viral infections. She has also been a principal investigator in several clinical trials of HIV-HCV co-infection. Dr. Klein is also involved in a number of observational epidemiologic research collaborations (e.g. NA-ACCORD and CANOC) focused on understanding longterm clinical and treatment outcomes in HIV and in HIV-HCV co-infection where she has assumed a leadership role in scientific steering committees. She is currently serving as IAS Governing Council representative for the North American Region. In 2014 she assumed the role of National Co-Director of the CIHR-Canadian HIV Trials Network.

Dr. Norah Terrault is the Professor of Medicine and the Director of the Viral Hepatitis Center at the University of California San Francisco. She is recognized nationally and internationally for her work related to viral hepatitis, especially in the setting of liver transplantation. She has authored more than 275 original articles, reviews and book chapters. She has served as Associate Editor for Hepatology and Deputy Editor for Liver Transplantation in the recent past and is current Associate Editor for Hepatology Communications. She is an investigator on several NIH-funded clinical studies in hepatitis B and NASH and is an investigator on several ongoing clinical trials of therapies for patients with chronic hepatitis B, hepatitis C and NASH.